Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Circulation. 1993;87:1854-1865

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Towbin, J. A.
Right arrow Articles by Swift, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Towbin, J. A.
Right arrow Articles by Swift, M.
Right arrowPubmed/NCBI databases
*OMIM
Medline Plus Health Information
*Cardiomyopathy
*Muscular Dystrophy
*Genetics Home Reference

Circulation, Vol 87, 1854-1865, Copyright © 1993 by American Heart Association

ARTICLES

X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus

JA Towbin, JF Hejtmancik, P Brink, B Gelb, XM Zhu, JS Chamberlain, ER McCabe and M Swift
Baylor College of Medicine, Department of Pediatrics, Houston, TX 77030.

BACKGROUND. X-linked cardiomyopathy (XLCM) is a rapidly progressive primary myocardial disorder presenting in teenage males as congestive heart failure. Manifesting female carriers have later onset (fifth decade) and slower progression. The purpose of this study was to localize the XLCM gene locus in two families using molecular genetic techniques. METHODS AND RESULTS. Linkage analysis using 60 X-chromosome- specific DNA markers was performed in a previously reported large XLCM pedigree and a smaller new pedigree. Two-point and multipoint linkage was calculated using the LINKAGE computer program package. Deletion analysis included multiplex polymerase chain reaction (PCR). Dystrophin protein was evaluated by Western blotting with N-terminal and C- terminal dystrophin antibody. Linkage of XLCM to the centromeric portion of the dystrophin or Duchenne muscular dystrophy (DMD) locus at Xp21 was demonstrated with combined maximum logarithm of the scores of +4.33, theta = 0 with probe XJ1.1 (DXS206) using two-point linkage and +4.81 at XJ1.1 with multipoint linkage analysis. LOD scores calculated using other proximal DMD genomic and cDNA probes and polymerase chain reaction polymorphisms supported linkage. No deletions were observed. Abnormalities of cardiac dystrophin were shown by Western blotting with N-terminal dystrophin antibody, whereas skeletal muscle dystrophin was normal, suggesting primary involvement of the DMD gene with preferential involvement of cardiac muscle. CONCLUSIONS. XLCM is due to an abnormality within the centromeric half of the dystrophin genomic region in heart. This abnormality could be due to 1) a point mutation in the 5' region of the DMD coding sequence preferentially affecting cardiac function, 2) a cardiac-specific promoter mutation that alters expression in this tissue, 3) splicing abnormalities, resulting in an abnormal cardiac protein, or 4) deletion mutations undetectable by Southern and multiplex polymerase chain reaction analysis.


This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
J. A. Towbin and M. Vatta
Myocardial Infarction, Viral Infection, and the Cytoskeleton: Final Common Pathways of a Common Disease?
J. Am. Coll. Cardiol., December 4, 2007; 50(23): 2215 - 2217.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. C. Silva, Z. M. A. Meira, J. Gurgel Giannetti, M. M. da Silva, A. F. Oliveira Campos, M. de Melo Barbosa, G. M. S. Filho, R. de Aguiar Ferreira, M. Zatz, and C. E. Rochitte
Myocardial Delayed Enhancement by Magnetic Resonance Imaging in Patients With Muscular Dystrophy
J. Am. Coll. Cardiol., May 8, 2007; 49(18): 1874 - 1879.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
D. Duan
Challenges and opportunities in dystrophin-deficient cardiomyopathy gene therapy
Hum. Mol. Genet., October 15, 2006; 15(suppl_2): R253 - R261.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
P. T. Ellinor, S. Sasse-Klaassen, S. Probst, B. Gerull, J. T. Shin, A. Toeppel, A. Heuser, B. Michely, D. M. Yoerger, B.-S. Song, et al.
A Novel Locus for Dilated Cardiomyopathy, Diffuse Myocardial Fibrosis, and Sudden Death on Chromosome 10q25-26
J. Am. Coll. Cardiol., July 4, 2006; 48(1): 106 - 111.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
N. J. Baxter, A. Roetzer, H.-D. Liebig, S. E. Sedelnikova, A. M. Hounslow, T. Skern, and J. P. Waltho
Structure and Dynamics of Coxsackievirus B4 2A Proteinase, an Enyzme Involved in the Etiology of Heart Disease
J. Virol., February 1, 2006; 80(3): 1451 - 1462.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
Section on Cardiology and Cardiac Surgery
Cardiovascular Health Supervision for Individuals Affected by Duchenne or Becker Muscular Dystrophy
Pediatrics, December 1, 2005; 116(6): 1569 - 1573.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
J. L. Jefferies, B. W. Eidem, J. W. Belmont, W. J. Craigen, S. M. Ware, S. D. Fernbach, S. R. Neish, E. O. Smith, and J. A. Towbin
Genetic Predictors and Remodeling of Dilated Cardiomyopathy in Muscular Dystrophy
Circulation, November 1, 2005; 112(18): 2799 - 2804.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
D. Sanoudou, E. Vafiadaki, D. A. Arvanitis, E. Kranias, and A. Kontrogianni-Konstantopoulos
Array lessons from the heart: focus on the genome and transcriptome of cardiomyopathies
Physiol Genomics, April 14, 2005; 21(2): 131 - 143.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
E. L. Burkett and R. E. Hershberger
Clinical and genetic issues in familial dilated cardiomyopathy
J. Am. Coll. Cardiol., April 5, 2005; 45(7): 969 - 981.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
T. M. Olson, V. V. Michels, J. D. Ballew, S. P. Reyna, M. L. Karst, K. J. Herron, S. C. Horton, R. J. Rodeheffer, and J. L. Anderson
Sodium Channel Mutations and Susceptibility to Heart Failure and Atrial Fibrillation
JAMA, January 26, 2005; 293(4): 447 - 454.
[Abstract] [Full Text] [PDF]

Home page
 Vet PatholHome page
A. Tidholm and L. Jonsson
Histologic Characterization of Canine Dilated Cardiomyopathy
Vet. Pathol., January 1, 2005; 42(1): 1 - 8.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
Y. De Repentigny, P. Marshall, R. G. Worton, and R. Kothary
The mouse dystrophin muscle enhancer-1 imparts skeletal muscle, but not cardiac muscle, expression onto the dystrophin Purkinje promoter in transgenic mice
Hum. Mol. Genet., November 15, 2004; 13(22): 2853 - 2862.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
N Cohen and F Muntoni
Multiple pathogenetic mechanisms in X linked dilated cardiomyopathy
Heart, August 1, 2004; 90(8): 835 - 841.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
Y. Yue, J. W. Skimming, M. Liu, T. Strawn, and D. Duan
Full-length dystrophin expression in half of the heart cells ameliorates {beta}-isoproterenol-induced cardiomyopathy in mdx mice
Hum. Mol. Genet., August 1, 2004; 13(15): 1669 - 1675.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
S. Karkkainen, T. Helio, R. Miettinen, P. Tuomainen, P. Peltola, J. Rummukainen, K. Ylitalo, M. Kaartinen, J. Kuusisto, L. Toivonen, et al.
A novel mutation, Ser143Pro, in the lamin A/C gene is common in finnish patients with familial dilated cardiomyopathy
Eur. Heart J., May 2, 2004; 25(10): 885 - 893.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. Vatta, S. J. Stetson, S. Jimenez, M. L. Entman, G. P. Noon, N. E. Bowles, J. A. Towbin, and G. Torre-Amione
Molecular normalization of dystrophin in the failing left and right ventricle of patients treated with either pulsatile or continuous flow-type ventricular assist devices
J. Am. Coll. Cardiol., March 3, 2004; 43(5): 811 - 817.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
J. A. Towbin
A noninvasive means of detecting preclinical cardiomyopathy in Duchenne muscular dystrophy?
J. Am. Coll. Cardiol., July 16, 2003; 42(2): 317 - 318.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. R. G. Taylor, P. R. Fain, G. Sinagra, M. L. Robinson, A. D. Robertson, E. Carniel, A. Di Lenarda, T. J. Bohlmeyer, D. A. Ferguson, G. L. Brodsky, et al.
Natural history of dilated cardiomyopathy due to lamin A/C gene mutations
J. Am. Coll. Cardiol., March 5, 2003; 41(5): 771 - 780.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
T. Konno, M. Shimizu, H. Ino, T. Matsuyama, M. Yamaguchi, H. Terai, K. Hayashi, T. Mabuchi, M. Kiyama, K. Sakata, et al.
A novel missense mutation in the myosin binding protein-C gene is responsible for hypertrophic cardiomyopathy with left ventricular dysfunction and dilation in elderly patients
J. Am. Coll. Cardiol., March 5, 2003; 41(5): 781 - 786.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
F. Muntoni
Cardiac Complications of Childhood Myopathies
J Child Neurol, March 1, 2003; 18(3): 191 - 202.
[Abstract] [PDF]

Home page
 Eur Heart J SupplHome page
N.E. Bowles
The molecular biology of dilated cardiomyopathy
Eur. Heart J. Suppl., December 1, 2002; 4(suppl_I): I2 - I7.
[Abstract] [PDF]

Home page
 Eur Heart J SupplHome page
A. Hjalmarson, M. Fu, and R. Mobini
Who are the enemies? Inflammation and autoimmune mechanisms
Eur. Heart J. Suppl., November 1, 2002; 4(suppl_G): G27 - G32.
[Abstract] [PDF]

Home page
 Physiol. Rev.Home page
D. Fatkin and R. M. Graham
Molecular Mechanisms of Inherited Cardiomyopathies
Physiol Rev, October 1, 2002; 82(4): 945 - 980.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
J. Feng, J. Yan, C. H. Buzin, S. S. Sommer, and J. A. Towbin
Comprehensive mutation scanning of the dystrophin gene in patients with nonsyndromic X-linked dilated cardiomyopathy
J. Am. Coll. Cardiol., September 18, 2002; 40(6): 1120 - 1124.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Stypmann, K. Glaser, W. Roth, D. J. Tobin, I. Petermann, R. Matthias, G. Monnig, W. Haverkamp, G. Breithardt, W. Schmahl, et al.
Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L
PNAS, April 18, 2002; (2002) 92637699.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Morimoto, Q.-W. Lu, K. Harada, F. Takahashi-Yanaga, R. Minakami, M. Ohta, T. Sasaguri, and I. Ohtsuki
Ca2+-desensitizing effect of a deletion mutation Delta K210 in cardiac troponin T that causes familial dilated cardiomyopathy
PNAS, January 1, 2002; (2002) 22628899.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
Y. Miyamoto, H. Akita, N. Shiga, E. Takai, C. Iwai, K. Mizutani, H. Kawai, A. Takarada, and M. Yokoyama
Frequency and clinical characteristics of dilated cardiomyopathy caused by desmin gene mutation in a Japanese population
Eur. Heart J., December 2, 2001; 22(24): 2284 - 2289.
[Abstract] [PDF]

Home page
 Hum Mol GenetHome page
C. Bastianutto, J. A. Bestard, K. Lahnakoski, D. Broere, M. De Visser, M. Zaccolo, T. Pozzan, A. Ferlini, F. Muntoni, T. Patarnello, et al.
Dystrophin muscle enhancer 1 is implicated in the activation of non-muscle isoforms in the skeletal muscle of patients with X-linked dilated cardiomyopathy
Hum. Mol. Genet., November 1, 2001; 10(23): 2627 - 2635.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Su, A. Yao, I. Zubair, K. Sugishita, M. Ritter, F. Li, J. J. Hunter, K. R. Chien, and W. H. Barry
Effects of deletion of muscle LIM protein on myocyte function
Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2665 - H2673.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
Y. Kamogawa, S. Biro, M. Maeda, M. Setoguchi, T. Hirakawa, H. Yoshida, and C. Tei
Dystrophin-deficient myocardium is vulnerable to pressure overload in vivo
Cardiovasc Res, June 1, 2001; 50(3): 509 - 515.
[Abstract] [Full Text] [PDF]

Home page
 ANGIOLOGYHome page
M. Saotome, Y. Yoshitomi, S. Kojima, and M. Kuramochi
Dilated Cardiomyopathy of Becker-Type Muscular Dystrophy with Exon 4 Deletion: A Case Report
Angiology, May 1, 2001; 52(5): 343 - 347.
[Abstract] [PDF]

Home page
 Eur Heart JHome page
A. Gavazzi, A. Repetto, L. Scelsi, C. Inserra, M.L. Laudisa, C. Campana, C. Specchia, B. Dal Bello, M. Diegoli, L. Tavazzi, et al.
Evidence-based diagnosis of familial non-X-linked dilated cardiomyopathy. Prevalence, inheritance and characteristics
Eur. Heart J., January 1, 2001; 22(1): 73 - 81.
[Abstract] [PDF]

Home page
 Cardiovasc ResHome page
J. Marin-Garcia, M. J Goldenthal, and G. W Moe
Mitochondrial pathology in cardiac failure
Cardiovasc Res, January 1, 2001; 49(1): 17 - 26.
[Full Text] [PDF]

Home page
 NEJMHome page
M. Kamisago, S. D. Sharma, S. R. DePalma, S. Solomon, P. Sharma, B. McDonough, L. Smoot, M. P. Mullen, P. K. Woolf, E. D. Wigle, et al.
Mutations in Sarcomere Protein Genes as a Cause of Dilated Cardiomyopathy
N. Engl. J. Med., December 7, 2000; 343(23): 1688 - 1696.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
E. Arbustini, P. Morbini, A. Pilotto, A. Gavazzi, and L. Tavazzi
Familial dilated cardiomyopathy: from clinical presentation to molecular genetics
Eur. Heart J., November 2, 2000; 21(22): 1825 - 1832.
[PDF]

Home page
 CirculationHome page
C. Badorff, B. Fichtlscherer, R. E. Rhoads, A. M. Zeiher, A. Muelsch, S. Dimmeler, and K. U. Knowlton
Nitric Oxide Inhibits Dystrophin Proteolysis by Coxsackieviral Protease 2A Through S-Nitrosylation : A Protective Mechanism Against Enteroviral Cardiomyopathy
Circulation, October 31, 2000; 102(18): 2276 - 2281.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
E. Arbustini, M. Diegoli, P. Morbini, B. Dal Bello, N. Banchieri, A. Pilotto, F. Magani, M. Grasso, J. Narula, A. Gavazzi, et al.
Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy
J. Am. Coll. Cardiol., June 1, 2000; 35(7): 1760 - 1768.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Badorff, N. Berkely, S. Mehrotra, J. W. Talhouk, R. E. Rhoads, and K. U. Knowlton
Enteroviral Protease 2A Directly Cleaves Dystrophin and Is Inhibited by a Dystrophin-based Substrate Analogue
J. Biol. Chem., April 6, 2000; 275(15): 11191 - 11197.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
G. L. Brodsky, F. Muntoni, S. Miocic, G. Sinagra, C. Sewry, and L. Mestroni
Lamin A/C Gene Mutation Associated With Dilated Cardiomyopathy With Variable Skeletal Muscle Involvement
Circulation, February 8, 2000; 101(5): 473 - 476.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
D. Fatkin, C. MacRae, T. Sasaki, M. R. Wolff, M. Porcu, M. Frenneaux, J. Atherton, H. J. Vidaillet, S. Spudich, U. De Girolami, et al.
Missense Mutations in the Rod Domain of the Lamin A/C Gene as Causes of Dilated Cardiomyopathy and Conduction-System Disease
N. Engl. J. Med., December 2, 1999; 341(23): 1715 - 1724.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
H. Swan, K. Piippo, M. Viitasalo, P.a. Heikkila, T. Paavonen, K. Kainulainen, J. Kere, P. Keto, K. Kontula, and L. Toivonen
Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts
J. Am. Coll. Cardiol., December 1, 1999; 34(7): 2035 - 2042.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
L. Mestroni, C. Rocco, D. Gregori, G. Sinagra, A. Di Lenarda, S. Miocic, M. Vatta, B. Pinamonti, F. Muntoni, A. L. P. Caforio, et al.
Familial dilated cardiomyopathy: Evidence for genetic and phenotypic heterogeneity
J. Am. Coll. Cardiol., July 1, 1999; 34(1): 181 - 190.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. G. Priori, J. Barhanin, R. N. W. Hauer, W. Haverkamp, H. J. Jongsma, A. G. Kleber, W. J. McKenna, D. M. Roden, Y. Rudy, K. Schwartz, et al.
Genetic and Molecular Basis of Cardiac Arrhythmias: Impact on Clinical Management Parts I and II
Circulation, February 2, 1999; 99(4): 518 - 528.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
S.G. Priori, J. Barhanin, R.N.W. Hauer, W. Haverkamp, H.J. Jongsma, A.G. Kleber, W.J. McKenna, D.M. Roden, Y. Rudy, K. Schwartz, et al.
Genetic and molecular basis of cardiac arrhythmias: Impact on clinical management
Eur. Heart J., February 1, 1999; 20(3): 174 - 195.
[PDF]

Home page
 CirculationHome page
S. Ichihara, Y. Yamada, and M. Yokota
Association of a G994->T Missense Mutation in the Plasma Platelet-Activating Factor Acetylhydrolase Gene With Genetic Susceptibility to Nonfamilial Dilated Cardiomyopathy in Japanese
Circulation, November 3, 1998; 98(18): 1881 - 1885.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
S. Stevenson, S. Rothery, M. J. Cullen, and N. J. Severs
Spatial Relationship of the C-Terminal Domains of Dystrophin and ß-Dystroglycan in Cardiac Muscle Support a Direct Molecular Interaction at the Plasma Membrane Interface
Circ. Res., January 23, 1998; 82(1): 82 - 93.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
F. Muntoni, A. Di Lenarda, M. Porcu, G. Sinagra, A. Mateddu, G. Marrosu, A. Ferlini, M. Cau, J. Milasin, M. A. Melis, et al.
Dystrophin gene abnormalities in two patients with idiopathic dilated cardiomyopathy
Heart, December 1, 1997; 78(6): 608 - 612.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
N. E. Bowles, Q. Wang, and J. A. Towbin
Prospects for adenovirus-mediated gene therapy of inherited diseases of the myocardium
Cardiovasc Res, September 1, 1997; 35(3): 422 - 430.
[Full Text] [PDF]

Home page
 CirculationHome page
A. H. Beggs
Dystrophinopathy, The Expanding Phenotype: Dystrophin Abnormalities in X-Linked Dilated Cardiomyopathy
Circulation, May 20, 1997; 95(10): 2344 - 2347.
[Full Text]

Home page
 CirculationHome page
R. Ortiz-Lopez, H. Li, J. Su, V. Goytia, and J. A. Towbin
Evidence for a Dystrophin Missense Mutation as a Cause of X-Linked Dilated Cardiomyopathy
Circulation, May 20, 1997; 95(10): 2434 - 2440.
[Abstract] [Full Text]

Home page
 Circ. Res.Home page
S. Stevenson, S. Rothery, M. J. Cullen, and N. J. Severs
Dystrophin Is Not a Specific Component of the Cardiac Costamere
Circ. Res., February 1, 1997; 80(2): 269 - 280.
[Abstract] [Full Text]

Home page
 CirculationHome page
P. Melacini, M. Fanin, G.A. Danieli, C. Villanova, F. Martinello, M. Miorin, M.P. Freda, M. Miorelli, M.L. Mostacciuolo, G. Fasoli, et al.
Myocardial Involvement Is Very Frequent Among Patients Affected With Subclinical Becker's Muscular Dystrophy
Circulation, December 15, 1996; 94(12): 3168 - 3175.
[Abstract] [Full Text]

Home page
 CirculationHome page
M. L. Schwartz, G. F. Cox, A. E. Lin, M. S. Korson, A. Perez-Atayde, R. V. Lacro, and S. E. Lipshultz
Clinical Approach to Genetic Cardiomyopathy in Children
Circulation, October 15, 1996; 94(8): 2021 - 2038.
[Abstract] [Full Text]

Home page
 CirculationHome page
H. R. Figulla, F. Gietzen, U. Zeymer, M. Raiber, J. Hegselmann, R. Soballa, and R. Hilgers
Diltiazem Improves Cardiac Function and Exercise Capacity in Patients With Idiopathic Dilated Cardiomyopathy: Results of the Diltiazem in Dilated Cardiomyopathy Trial
Circulation, August 1, 1996; 94(3): 346 - 352.
[Abstract] [Full Text]

Home page
 NEJMHome page
R. Fadic, Y. Sunada, A. J. Waclawik, S. Buck, P. J. Lewandoski, K. P. Campbell, and B. P. Lotz
Deficiency of a Dystrophin-Associated Glycoprotein (Adhalin) in a Patient with Muscular Dystrophy and Cardiomyopathy
N. Engl. J. Med., February 8, 1996; 334(6): 362 - 366.
[Full Text] [PDF]

Home page
 CirculationHome page
J.-B. Durand, L. L. Bachinski, L. C. Bieling, G. Z. Czernuszewicz, A. B. Abchee, Q. Tao Yu, T. Tapscott, R. Hill, J. Ifegwu, A.J. Marian, et al.
Localization of a Gene Responsible for Familial Dilated Cardiomyopathy to Chromosome 1q32
Circulation, December 15, 1995; 92(12): 3387 - 3389.
[Abstract] [Full Text]

Home page
 CirculationHome page
A.J. Marian and R. Roberts
Recent Advances in the Molecular Genetics of Hypertrophic Cardiomyopathy
Circulation, September 1, 1995; 92(5): 1336 - 1347.
[Full Text]